Literature DB >> 16626772

Releasing or expression modulating mediator involved in hemostasis by Berythractivase and Jararhagin (SVMPs).

Agostinho Luiz Maia Pereira1, Márcio Fritzen, Fernanda Faria, Guacyara da Motta, Ana Marisa Chudzinski-Tavassi.   

Abstract

PIII snake venom metalloproteases (SVMPs) are structurally related to ADAMs (a disintegrin and metalloprotease human family of proteins). Berythractivase and Jararhagin are PIII SVMPs with 69% homology with different hemostatic properties. In order to clarify these differences and further characterize the biological effects of these proteins, we compared the effect of both proteases on human umbilical vein endothelial cell (HUVEC) for evaluating the release and modulation of coagulation and fibrinolysis mechanisms as well as the expression of their correlated genes. We found that both proteins increase the von Willebrand factor liberation, but did not modulate gene expression. Berythractivase, differently from Jararhagin increased the expression of tissue factor. Our results showed that both SVMPs (Berythractivase and Jararhagin) activate HUVEC releasing or modulating mediators involved in hemostasis. Meanwhile, we can suggest through the up-regulation of TF gene that the studied SVMP acts in a specific manner, suggesting that Jararhagin has preferentially a local action, while Berythractivase can be assumed as a systemic pro-coagulant protein with activity on the surface of HUVECs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16626772     DOI: 10.1016/j.toxicon.2006.02.014

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  6 in total

1.  Contribution of endothelial cell and macrophage activation in the alterations induced by the venom of Micrurus tener tener in C57BL/6 mice.

Authors:  Emelyn Salazar; Ana María Salazar; Peter Taylor; Izaskun Urdanibia; Karin Pérez; Alexis Rodríguez-Acosta; Elda E Sánchez; Belsy Guerrero
Journal:  Mol Immunol       Date:  2019-10-07       Impact factor: 4.407

2.  Enzymatic and Pro-Inflammatory Activities of Bothrops lanceolatus Venom: Relevance for Envenomation.

Authors:  Marie Delafontaine; Isadora Maria Villas-Boas; Laurence Mathieu; Patrice Josset; Joël Blomet; Denise V Tambourgi
Journal:  Toxins (Basel)       Date:  2017-08-07       Impact factor: 4.546

Review 3.  Inflammation Induced by Platelet-Activating Viperid Snake Venoms: Perspectives on Thromboinflammation.

Authors:  Catarina Teixeira; Cristina Maria Fernandes; Elbio Leiguez; Ana Marisa Chudzinski-Tavassi
Journal:  Front Immunol       Date:  2019-09-04       Impact factor: 7.561

4.  Bothrops jararaca venom metalloproteinases are essential for coagulopathy and increase plasma tissue factor levels during envenomation.

Authors:  Karine M Yamashita; André F Alves; Katia C Barbaro; Marcelo L Santoro
Journal:  PLoS Negl Trop Dis       Date:  2014-05-15

5.  Bleeding Disorders in Bothrops atrox Envenomations in the Brazilian Amazon: Participation of Hemostatic Factors and the Impact of Tissue Factor.

Authors:  Sâmella S Oliveira; Eliane C Alves; Alessandra S Santos; Elizandra F Nascimento; João Pedro T Pereira; Iran M Silva; Jacqueline A G Sachett; Lybia Kássia S Sarraff; Luciana Aparecida Freitas-de-Sousa; Mônica Colombini; Hedylamar O Marques; Marcus V G Lacerda; Marco Aurélio Sartim; Ana Maria Moura-da-Silva; Luiz Carlos L Ferreira; Ida S Sano-Martins; Wuelton M Monteiro
Journal:  Toxins (Basel)       Date:  2020-08-29       Impact factor: 4.546

6.  Correlating Fibrinogen Consumption and Profiles of Inflammatory Molecules in Human Envenomation's by Bothrops atrox in the Brazilian Amazon.

Authors:  Irmgardt Alicia María Wellmann; Hiochelson Najibe Santos Ibiapina; Jacqueline Almeida Gonçalves Sachett; Marco Aurélio Sartim; Iran Mendonça Silva; Sâmella Silva Oliveira; Andréa Monteiro Tarragô; Ana Maria Moura-da-Silva; Marcus Vinícius Guimarães Lacerda; Luiz Carlos de Lima Ferreira; Adriana Malheiro; Wuelton Marcelo Monteiro; Allyson Guimarães Costa
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.